Compare FRMM & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRMM | IMA |
|---|---|---|
| Founded | N/A | 2019 |
| Country | United States | United States |
| Employees | N/A | 15 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.9M | 65.3M |
| IPO Year | 2017 | N/A |
| Metric | FRMM | IMA |
|---|---|---|
| Price | $1.93 | $4.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 314.8K | 33.9K |
| Earning Date | 05-15-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.00 | $3.94 |
| 52 Week High | $3.17 | $17.50 |
| Indicator | FRMM | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 19.52 | 37.84 |
| Support Level | N/A | $3.94 |
| Resistance Level | $3.14 | $7.17 |
| Average True Range (ATR) | 0.26 | 0.38 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 3.12 | 48.58 |
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.